NATIONAL JEWISH HEALTH
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Identification of Epidermal Signatures in Patients With Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- Procedure: Skin BiopsyProcedure: Skin tape strippingProcedure: Blood draw
- First Posted Date
- 2016-02-11
- Last Posted Date
- 2019-05-10
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 50
- Registration Number
- NCT02680405
- Locations
- 🇺🇸
National Jewish Health and University of Colorado Denver, Denver, Colorado, United States
Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe CF
- First Posted Date
- 2015-12-10
- Last Posted Date
- 2019-07-24
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 14
- Registration Number
- NCT02626182
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Exposure in Epigenetic Regulation of Immune Response in Chronic Beryllium Disease (CBD)
- Conditions
- Chronic Beryllium Disease
- Interventions
- Other: Nothing
- First Posted Date
- 2015-11-13
- Last Posted Date
- 2021-04-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 148
- Registration Number
- NCT02604693
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
The Role of JAK2 in Alveolar Macrophages (AM's) in Chronic Beryllium Disease (CBD)
- Conditions
- Chronic Beryllium Disease (CBD)Beryllium Sensitization (BeS)
- Interventions
- Procedure: Blood drawProcedure: bronchoscopy
- First Posted Date
- 2015-11-04
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 3
- Registration Number
- NCT02596347
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
COPDGene/Lung Cancer Center Database
- Conditions
- COPDLung Cancer
- Interventions
- Other: None, N/A
- First Posted Date
- 2015-05-15
- Last Posted Date
- 2021-03-04
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 250
- Registration Number
- NCT02445183
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis
- Conditions
- Cystic Fibrosis
- First Posted Date
- 2015-04-17
- Last Posted Date
- 2024-04-02
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 70
- Registration Number
- NCT02419989
- Locations
- 🇺🇸
Nationwide Children's Hospital, Columbus, Ohio, United States
🇺🇸University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸Northwestern University, Chicago, Illinois, United States
Glycerol Phenylbutyrate Corrector Therapy For CF (Cystic Fibrosis)
- Conditions
- Cystic Fibrosis
- Interventions
- First Posted Date
- 2014-12-23
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 13
- Registration Number
- NCT02323100
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
🇺🇸Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
🇺🇸Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Tailored Treatment to Enhance Risk Perception in Sleep Apnea
- Conditions
- Obstructive Sleep Apnea (OSA)
- Interventions
- Behavioral: Brief Personalized Video (BPV)Behavioral: Non-Personalized Video (NPV)Behavioral: Treatment as Usual (TAU)
- First Posted Date
- 2014-12-11
- Last Posted Date
- 2021-06-30
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 284
- Registration Number
- NCT02314858
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension
- First Posted Date
- 2014-08-20
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 10
- Registration Number
- NCT02220634
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Ambrisentan for the Improvement in Right Ventricular Strain in Scleroderma Associated Pulmonary Arterial Hypertension
- First Posted Date
- 2014-06-23
- Last Posted Date
- 2021-01-19
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 7
- Registration Number
- NCT02169752
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States